EVALUATION OF INTERACTIONS OF SARS-COV-2 STRUCTURAL PROTEINS WITH SPECIFIC ANTIBODIES BY SPR ASSAY

EVALUATION OF INTERACTIONS OF SARS-COV-2 STRUCTURAL PROTEINS WITH SPECIFIC ANTIBODIES BY SPR ASSAY

Background: The World Health Organization admitted that the vaccination against Covid 19 limited the deaths, but not the spread of the disease. This requires a method allowing a specific, rapid and accurate diagnosis of the disease. We report a SPR assay that meets the requirements and can be appli...

Full description

Bibliographic Details
Main Authors:	Petia Genova-Kalou, Georgi Dyankov, Hristo Kisov, Vihar Mankov, Evdokiya Hikova, Stefka Krumova, Nikola Malinowski
Format:	Article
Language:	English
Published:	National Center of Infectious and Parasitic Diseases 2023-08-01
Series:	Problems of Infectious and Parasitic Diseases
Subjects:	SARS-CoV-2 spike (S-) protein nucleocapsid (N-) protein anti-SARS-CoV-1/2 antibodies Surface Plasmon Resonance (SPR) assay
Online Access:	https://pipd.ncipd.org/index.php/pipd/article/view/104

Similar Items

Binding of SARS-CoV-2 Structural Proteins to Hemoglobin and Myoglobin Studied by SPR and DR LPG
by: Georgi Dyankov, et al.
Published: (2023-03-01)

Capabilities of Double-Resonance LPG and SPR Methods for Hypersensitive Detection of SARS-CoV-2 Structural Proteins: A Comparative Study
by: Tinko Eftimov, et al.
Published: (2023-02-01)

Detection of Helicobacter pylori in saliva based on surface plasmon resonance by binding of Lewis b (Leb) blood group antigen to specific adhesin BabA
by: Georgi Dyankov, et al.
Published: (2024-12-01)

SPR-Based Kinetic Analysis of the Early Stages of Infection in Cells Infected with Human Coronavirus and Treated with Hydroxychloroquine
by: Petia Genova-Kalou, et al.
Published: (2021-07-01)

Human cytokine and coronavirus nucleocapsid protein interactivity using large-scale virtual screens
by: Phillip J. Tomezsko, et al.
Published: (2024-05-01)

SARS-Arena: Sequence and Structure-Guided Selection of Conserved Peptides from SARS-related Coronaviruses for Novel Vaccine Development
by: Mauricio Menegatti Rigo, et al.
Published: (2022-07-01)

Sensitive and Specific Immunohistochemistry Protocol for Nucleocapsid Protein from All Common SARS-CoV-2 Virus Strains in Formalin-Fixed, Paraffin Embedded Tissues
by: Yunguang Sun, et al.
Published: (2021-07-01)

Nucleocapsid Protein of SARS-CoV-2 Upregulates RANTES Expression in A172 Glioblastoma Cells
by: Bakhytgul Gadilgereyeva, et al.
Published: (2025-02-01)

Inhibition of SARS-CoV-2 replication by a ssDNA aptamer targeting the nucleocapsid protein
by: Yanping Huang, et al.
Published: (2024-04-01)

Immunized mice naturally process in silico-derived peptides from the nucleocapsid of SARS-CoV-2
by: Mario Aldair Campos-Ruíz, et al.
Published: (2023-10-01)

Vertical Transmission of SARS-CoV-2 Infection and Miscarriage in the Second Trimester: Report of an Immunohistochemically Proven Case
by: Dimitar Metodiev, et al.
Published: (2022-07-01)

SPR and Double Resonance LPG Biosensors for <i>Helicobacter pylori</i> BabA Antigen Detection
by: Georgi Dyankov, et al.
Published: (2024-03-01)

Production and Characterization of Nucleocapsid and RBD Cocktail Antigens of SARS-CoV-2 in <i>Nicotiana benthamiana</i> Plant as a Vaccine Candidate against COVID-19
by: Tarlan Mamedov, et al.
Published: (2021-11-01)

Age, Disease Severity and Ethnicity Influence Humoral Responses in a Multi-Ethnic COVID-19 Cohort
by: Muneerah Smith, et al.
Published: (2021-04-01)

Temporal analysis and comparative genomic study of SARS-CoV-2 variants across Uttar Pradesh, India: Insights from the first and second COVID-19 waves
by: Vineeta Sharma, et al.
Published: (2024-06-01)

COVID-19 Seroprevalence in a Mixed Cohort of SARS-CoV-2 PCR Positive and Exposed Subjects
by: Giles Knowles, et al.
Published: (2023-05-01)

Combination of Recombinant Proteins S1/N and RBD/N as Potential Vaccine Candidates
by: Noe Juvenal Mendoza-Ramírez, et al.
Published: (2023-04-01)

Development of in-house ELISAs for the detection of anti-SARS‑CoV‑2 RBD and N IgG and IgM antibodies in biological samples
by: Essam H. Ibrahim, et al.
Published: (2021-06-01)

SARS-CoV-2 nucleocapsid protein interaction with YBX1 displays oncolytic properties through PKM mRNA destabilization
by: Xin Chen, et al.
Published: (2024-11-01)

The SARS-CoV-2 Nucleocapsid Protein and Its Role in Viral Structure, Biological Functions, and a Potential Target for Drug or Vaccine Mitigation
by: Zhihua Bai, et al.
Published: (2021-06-01)

Lateral Flow Immunoassay Coupled with Copper Enhancement for Rapid and Sensitive SARS-CoV-2 Nucleocapsid Protein Detection
by: Tao Peng, et al.
Published: (2021-12-01)

Immunogenicity and In Vivo Protective Effects of Recombinant Nucleocapsid-Based SARS-CoV-2 Vaccine Convacell<sup>®</sup>
by: Sevastyan O. Rabdano, et al.
Published: (2023-04-01)

SARS-CoV-2 Nucleocapsid Protein Has DNA-Melting and Strand-Annealing Activities With Different Properties From SARS-CoV-2 Nsp13
by: Bo Zhang, et al.
Published: (2022-07-01)

Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic
by: Carmen L. Charlton, et al.
Published: (2021-09-01)

Long-Term Humoral Immune Response against SARS-CoV-2 after Natural Infection and Subsequent Vaccination According to WHO International Binding Antibody Units (BAU/mL)
by: Natalia Ruetalo, et al.
Published: (2021-11-01)

Structural and Phylogenetic Analysis of SARS-CoV-2 Spike Glycoprotein from the Most Widespread Variants
by: Emilia Caputo, et al.
Published: (2022-08-01)

HuCoPIA: An Atlas of Human vs. SARS-CoV-2 Interactome and the Comparative Analysis with Other <i>Coronaviridae</i> Family Viruses
by: Naveen Duhan, et al.
Published: (2023-02-01)

Contribution to pathogenesis of accessory proteins of deadly human coronaviruses
by: Jesus Hurtado-Tamayo, et al.
Published: (2023-05-01)

A multi-population-based genomic analysis uncovers unique haplotype variants and crucial mutant genes in SARS-CoV-2
by: Afzal Sheikh, et al.
Published: (2022-11-01)

Nucleocapsid as a next-generation COVID-19 vaccine candidate
by: Bryan Oronsky, et al.
Published: (2022-09-01)

SARS-CoV-2 anti-RBD and anti-N protein responses are differentially regulated between mother-child pairs: insight from a national study cohort at the Faroe Islands
by: Ida Jarlhelt, et al.
Published: (2024-07-01)

Five Commercial Immunoassays for SARS-CoV-2 Antibody Determination and Their Comparison and Correlation with the Virus Neutralization Test
by: Václav Šimánek, et al.
Published: (2021-03-01)

Monoclonal Antibodies to S and N SARS-CoV-2 Proteins as Probes to Assess Structural and Antigenic Properties of Coronaviruses
by: Rinki Kumar, et al.
Published: (2021-09-01)

Protective Role of Vitamin K3 on SARS-CoV-2 Structural Protein-Induced Inflammation and Cell Death
by: Yixiong Zhan, et al.
Published: (2023-08-01)

Humoral Immune Response to CoronaVac in Turkish Adults
by: Yasemin Cosgun, et al.
Published: (2023-01-01)

Validation of N Protein Antibodies to Diagnose Previous SARS-CoV-2 Infection in a Large Cohort of Healthcare Workers: Use of Roche Elecsys<sup>®</sup> Immunoassay in the S Protein Vaccination Era
by: Juan Francisco Delgado, et al.
Published: (2023-04-01)

Natural versus Recombinant Viral Antigens in SARS-CoV-2 Serology: Challenges in Optimizing Laboratory Diagnosis of COVID-19
by: Luciana Regina Meireles, et al.
Published: (2020-12-01)

Aptamer-Mediated Electrochemical Detection of SARS-CoV-2 Nucleocapsid Protein in Saliva
by: Ryan H. P. Siu, et al.
Published: (2024-09-01)

Molecular characterization of SARS-CoV-2 nucleocapsid protein
by: Yanping Huang, et al.
Published: (2024-05-01)

The Interaction between SARS-CoV-2 Nucleocapsid Protein and UBC9 Inhibits MAVS Ubiquitination by Enhancing Its SUMOylation
by: Congcong Huang, et al.
Published: (2023-11-01)